You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TPO RA (thrombopoietin receptor agonists )

Showing 1 - 25 of 9,110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

Recruiting
  • Aplastic Anemia
  • +2 more
  • Beijing, China
    Peking union medical college hospital
Aug 20, 2023

Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • (no location specified)
Jun 5, 2023

Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • eltrombopag and romiplastim
  • (no location specified)
Nov 16, 2023

Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

Not yet recruiting
  • Stem Cell Transplant Complications
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 17, 2022

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Dec 29, 2022

Persistent or Chronic ITP Trial in Creteil (Tpo-RA discontinuation)

Unknown status
  • Persistent or Chronic ITP
  • Tpo-RA discontinuation
  • Creteil, France
    Henri-Mondor Hospital
Feb 17, 2020

Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)

Not yet recruiting
  • Primary Immune Thrombocytopenia
  • 2.5mg/d Hetrombopag
  • (no location specified)
Mar 28, 2022

Tumor Therapy-related Thrombocytopenia Trial (TPO-RA (Herombopag), TPO-RA (Herombopag) and rhTPO(Recombinant human

Not yet recruiting
  • Tumor Therapy-related Thrombocytopenia
  • TPO-RA (Herombopag)
  • TPO-RA (Herombopag) and rhTPO(Recombinant human thrombopoietin)
  • (no location specified)
Apr 27, 2022

GLP-1 Receptor Agonists on Efficacy and Persistence, Adherence

Completed
  • Type 2 Diabetes
  • Obesity
  • Valencia, Spain
    INCLIVA
Sep 6, 2022

MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Thrombocytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 8, 2022

Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)

Recruiting
  • Immune Thrombocytopenia Purpura
  • Cairo, Egypt
    EL-Kasr elineiy
May 6, 2023

A Pan-European Post-Authorisation Safety Study: Risk of

Not yet recruiting
  • Pancreatic Cancer
  • Exenatide
  • Non-GLP-1 RA based glucose lowering drugs
  • (no location specified)
Dec 21, 2022

Based on Data From German Sick Funds That Looks at Costs of

Completed
  • Diabetes Mellitus, Type 2
  • Ingelheim am Rhein, Germany
    Boehringer Ingelheim
Jan 18, 2022

Moderate Aplastic Anemia, Unilineage Bone Marrow Failure Disorders Trial run by the NHLBI (Eltrombopag)

Active, not recruiting
Has Results
  • Moderate Aplastic Anemia
  • Unilineage Bone Marrow Failure Disorders
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 2, 2021

Antiphospholipid Syndrome, Thrombocytopenia Trial in Tianjin (Anti-CD38 antibody Injection)

Recruiting
  • Antiphospholipid Syndrome
  • Thrombocytopenia
  • Anti-CD38 antibody Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023

Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

Recruiting
  • Hematological Disease
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023

Anemia, Aplastic, Anemia, Hypoplastic, Thrombocytopenia Trial run by the NHLBI (Eltrombopag)

Completed
Has Results
  • Anemia, Aplastic
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 30, 2020

Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Not yet recruiting
  • Thrombopoietin Receptor Agonist
    • (no location specified)
    May 4, 2023

    Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)

    Not yet recruiting
    • Aplastic Anemia
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

    Recruiting
    • Autoimmune Hemolytic Anemia
    • +5 more
    • cytokine essays
    • +6 more
    • Milano, Italy
      Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
    Jul 3, 2023

    A Study of Switching Avatrombopag and Rh-TPO in ITP

    Not yet recruiting
    • Corticosteroid-resistant or Relapsed ITP
      • (no location specified)
      May 29, 2021

      Immune Thrombocytopenia Trial (Daratumumab Injection)

      Not yet recruiting
      • Immune Thrombocytopenia
      • Daratumumab Injection
      • (no location specified)
      Sep 28, 2022

      Immune Thrombocytopenia, Treatment Trial in Tianjin (CM313 Injection)

      Not yet recruiting
      • Immune Thrombocytopenia
      • Treatment
      • CM313 Injection
      • Tianjin, Tianjin, China
        Chinese Academy of Medical Science and Blood Disease Hospital
      Jan 12, 2023

      Eltrombopag and Recombinant Human Thrombopoietin In Primary

      Unknown status
      Has Results
      • Corticosteroid-resistant or Relapsed ITP
      • Beijing, Beijing, China
        Peking University Institute of Hematology
      Oct 17, 2020

      Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)

      Not yet recruiting
      • Morbid Obesity
      • +4 more
      • GLP-1 receptor agonist
      • Columbia, Missouri
        University of Missouri Hospital
      Nov 20, 2023